previous arrow
next arrow
Slider
previous arrow
next arrow
Slider
Up to  0
people worldwide may have
primary aldosterone
0
do not know
they do
0
could be
surgically cured
0
could be
medically treated

Although it affects millions of hypertensives, primary aldosteronism is mistakenly considered “rare.”
Understanding of the disease remains fragmented, and it is seldom diagnosed and treated.

Although it affects millions of hypertensives, primary aldosteronism is mistakenly considered “rare.” Understanding of the disease remains fragmented, and it is seldom adequately diagnosed and treated.

Welcome to the Primary Aldosteronism Foundation

A Patient-Driven Initiative Dedicated to Advocacy, Education, and Research

We are a patient initiative created to raise awareness of the prevalence of primary aldosteronism, encourage timely diagnosis and treatment, foster accelerated research, and facilitate patient collaboration.

We help those who have, or suspect they have primary aldosteronism, navigate the road to accurate diagnosis, obtain adequate and effective treatment, stay abreast of relevant medical advances, and optimize care.

We serve the primary aldosteronism community worldwide and are headquartered in the US state of Arizona.
Whether you or someone you know have high blood pressure that is long-standing and/or difficult to control, help us support the development of adequate responses to primary aldosteronism by signing the Foundation’s Open Letter.

We serve the primary aldosteronism community worldwide and are headquartered in the US state of Arizona.

Whether you or someone you know have hypertension that is long-standing and/or difficult to control, help us support the development of adequate responses to primary aldosteronism by signing the Foundation’s Open Letter.

Physicians and nurses in a hospital hallway
Find a PA Expert
International specialists treating
primary aldosteronism.​
Front entrance of Mayo Clinic, Rochester, Minnesota
Find a Center of Excellence
Dedicated PA departments at
medical centers worldwide.​
Smartphone resting on keyboard showing social media app
Find Support
Over 1,600 patients are helping
each other on Facebook.
Green seedling with soil held in palm of two outstretched hands
It Takes a Village
Each contribution helps
to make a difference.
Blue medication capsule above a spark-PA logo
New Aldosterone Inhibitor
A clinical research study is
recruiting PA participants.
Coronavirus showing spike proteins
PA and COVID-19
Underlying conditions like PA
affect disease outcome.

©2021 Primary Aldosteronism Foundation — All Rights Reserved

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.

©2021 Primary Aldosteronism Foundation

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.